Copaxone

Copaxone

glatiramer acetate

Manufacturer:

Norton Healthcare

Distributor:

DKLL

Marketer:

Teva Pharma
Concise Prescribing Info
Contents
Glatiramer acetate
Indications/Uses
Relapsing forms of multiple sclerosis (MS).
Dosage/Direction for Use
Adult 40 mg as SC inj 3 times wkly w/ at least 48 hr apart.
Contraindications
Special Precautions
Not to be administered as IV or IM. Discontinue treatment if severe adverse event occurs. Patients w/ pre-existing cardiac disorders. Monitor renal function during treatment. Pregnancy & lactation. Childn <18 yr.
Adverse Reactions
Infection, flu; anxiety, depression; headache; vasodilatation; dyspnoea; nausea; rash; arthralgia, back pain; asthenia, chest pain, inj site reactions, pain. Bronchitis, gastroenteritis, herpes simplex, otitis media, rhinitis, tooth abscess, vag candidiasis; benign neoplasm of skin, neoplasm; lymphadenopathy; hypersensitivity; anorexia, increased wt; nervousness; dysgeusia, hypertonia, migraine, speech disorder, syncope, tremor; diplopia, eye disoder; ear disorder; palpitations, tachycardia; cough, seasonal rhinitis; anorectal disorder, constipation, dental caries, dyspepsia, dysphagia, faecal incontinence, vomiting; abnormal LFT; ecchymosis, hyperhidrosis, pruritus, skin disorder, urticaria; neck pain; micturition urgency, pollakiuria, urinary retention; chills, face oedema, inj site atrophy, local reaction, peripheral oedema, oedema, pyrexia.
Drug Interactions
Increased incidence of inj site reactions w/ corticosteroids. May have potential to affect distribution of protein-bound substances w/ phenytoin or carbamazepine.
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
L03AX13 - glatiramer acetate ; Belongs to the class of other immunostimulants.
Presentation/Packing
Form
Copaxone soln for inj 40 mg/mL
Packing/Price
12 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in